Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 247 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
32 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-VORICONAZOLE | 200MG | TABLET | Resolved | 2018-07-11 | 2018-09-12 | 55293 |
APO-VORICONAZOLE | 50MG | TABLET | Resolved | 2018-07-11 | 2018-09-12 | 55296 |
APO-FELODIPINE | 5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-07-11 | 2018-08-01 | 55299 |
APO-TELMISARTAN | 40MG | TABLET | Resolved | 2018-07-15 | 2018-09-12 | 55794 |
APO-TELMISARTAN | 80MG | TABLET | Resolved | 2018-07-15 | 2018-09-12 | 55798 |
APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Resolved | 2018-07-15 | 2018-09-15 | 55807 |
APO-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-07-16 | 2018-10-02 | 55836 |
APO-FUROSEMIDE | 40MG | TABLET | Resolved | 2018-07-16 | 2018-09-11 | 55839 |
APO-OLANZAPINE | 15.0MG | TABLET | Resolved | 2018-07-16 | 2018-10-12 | 55842 |
APO-SERTRALINE | 25MG | CAPSULE | Resolved | 2018-07-16 | 2018-08-31 | 55847 |
APO-TENOFOVIR | 300MG | TABLET | Resolved | 2018-07-25 | 2018-09-04 | 56538 |
APO-METHYLPHENIDATE ER | 54MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-07-25 | 2018-10-25 | 56541 |
APO-FUROSEMIDE | 20MG | TABLET | Resolved | 2018-07-31 | 2018-10-11 | 56983 |
APO-IMATINIB | 400MG | TABLET | Resolved | 2018-07-31 | 2018-11-15 | 56986 |
APO-QUETIAPINE | 300MG | TABLET | Resolved | 2018-07-31 | 2018-09-28 | 56989 |
APO-AMLODIPINE | 5.0MG | TABLET | Resolved | 2018-08-09 | 2018-09-29 | 57766 |
APO-ARIPIPRAZOLE | 15MG | TABLET | Resolved | 2018-08-09 | 2018-09-08 | 57769 |
APO-ATENOL TAB 100MG | 100MG | TABLET | Resolved | 2018-08-09 | 2018-10-13 | 57772 |
APO-CINACALCET | 30MG | TABLET | Resolved | 2018-08-09 | 2018-11-23 | 57775 |
APO-CLINDAMYCIN | 300MG | CAPSULE | Resolved | 2018-08-09 | 2018-10-26 | 57779 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-SULIN TAB 200MG | 200MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1172 |
APO-SULIN TAB 150MG | 150mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1186 |
APO CHLORPROPAMIDE TAB 100MG | 100MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1196 |
APO CHLORPROPAMIDE TAB 250MG | 250 mg | tablet | Discontinued | 2017-03-13 | 2018-02-05 | 1235 |
APO-DOXY TABS 100MG | 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4707 |
APO-FLUVOXAMINE | 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4713 |
APO-FLUVOXAMINE | 50MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4716 |
APO-FUROSEMIDE | 80MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4719 |
APO-NAPROXEN | 250MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4734 |
APO-OLANZAPINE | 2.5MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4738 |
APO-TERAZOSIN | 1MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4745 |
APO-TERAZOSIN | 5MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4749 |
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | 125MG 31.25MG | POWDER FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4903 |
APO-AMOXI CLAV 250MG/62.5MG PER 5ML | 250MG 62.5MG | POWDER FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4906 |
APO-DICLO SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4909 |
APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4915 |
APO-GEMFIBROZIL CAP 300MG USP | 300MG | CAPSULE | Discontinued | 2017-03-31 | 2018-12-07 | 4920 |
APO-GEMFIBROZIL | 600MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4927 |
APO-LOPERAMIDE | 2MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4930 |
APO-SOTALOL | 80MG | TABLET | Discontinued | 2017-03-31 | 2018-12-07 | 4936 |